At a median of @ months of follow-up , there had been @ instances of disease progression in the radiotherapy group , and @ patients had died ( @ with disease progression , @ of whom died from Hodgkin 's lymphoma ) ; there had been @ instances of disease progression in the group with no further therapy , and @ patients had died ( @ with disease progression and none from Hodgkin 's lymphoma ) .